|
Market Cap (24-May) $241,483,296 (417th) |
Close (30-Jun) $1.23 |
Volume (30-Jun) 249,053 |
Shortsold (5-May) 39,772 (0.02%) (495th) |
|
52w High $2.09 |
52w Low $0.92 |
P/E - |
EPS -0.05 |
RAC released this announcement to the ASX on 10 March 2022, 9:26. The announcement is marked as price sensitive, and is 18 page(s) in length and 1.79MB in size.
You can view all announcements from RAC and see how they appear on a price chart on the announcements page.
At the date of this announcement, RAC was 0.011% short sold according to ASIC data. It was ranked the 609th most shorted stock on the ASX. It is now ranked as the 495th most shorted stock on the ASX with 0.023% of total shares short sold as of the latest reported data (05 May 2025).
| Other Recent Announcements from RAC | |
|---|---|
| Notification of cessation of securities - RAC | 29 June 2023, 9:54 |
| Proposed issue of securities - RAC | 29 June 2023, 9:52 |
| Initial Director's Interest Notice | 29 June 2023, 9:46 |
| Compelling Zantrene Preclinical Kidney Cancer Data | 10 March 2022, 9:26 |
| Cleansing Notice | 7 March 2022, 13:59 |
| Application for quotation of securities - RAC | 7 March 2022, 13:57 |
| Appendix 3Y - Dr Daniel Tillett | 4 March 2022, 13:53 |
You must be logged in to post a reply.
Race Oncology 